Viewing StudyNCT00260364



Ignite Creation Date: 2024-05-05 @ 12:11 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00260364
Status: COMPLETED
Last Update Posted: 2016-10-14
First Post: 2005-11-29

Brief Title: Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer
Sponsor: Royal Marsden NHS Foundation Trust
Organization: Royal Marsden NHS Foundation Trust

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer
Keywords:
Name View
Stage IVB carcinoma of the pancreas View
Recurrent carcinoma of the pancreas View
Adenocarcinoma of the pancreas View
Stage II carcinoma of the pancreas View
Stage III carcinoma of the pancreas View
Stage IVA carcinoma of the pancreas View